Pan-Viral ACTIONS Initiative

Target Audience

This educational initiative is intended for addiction-services providers: MDs, NPs, PAs, counselors, nurses, case managers, peer educators, and nonclinical office staff.

Learning Objectives

Upon completion of this program, participants will be better able to:

• Define current screening guidelines for HIV, HCV, and HBV, including for people at high risk

• Identify optimal community- and clinic-specific strategies to efficiently conduct pan-viral screening for HIV, HCV, and HBV

• Establish linkage to care pathways for patients who require follow-up for HIV, HCV, or HBV treatment or prevention

Program Description

Patients with substance use disorder (SUD), particularly people who inject drugs (PWID), are at increased risk for contracting HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV). A key measure to diagnosing people and mitigating infection spread in the population is testing, ideally pan-viral screening of all 3 infections at once, or triple screening. SUD centers can play a significant role in triple screening. Point-of-care rapid tests are available for HIV and HCV, and HBV testing can be performed in a laboratory. This on-site educational initiative at SUD centers will broaden staff understanding of the importance of triple screening, review guidelines on testing and available tests, provide guidance identifying where triple screening fits into a clinic’s workflow, and prepare staff to refer patients in need of treatment or additional prevention measures.

Agenda

• Epidemiology and burden of HIV, HCV, and HBV in the context of SUD

• Current screening guidelines for HIV, HCV, and HBV

• Pan-viral testing for diagnosis

• Establishing care pathways following test results

• Audience Q&A

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Integritas designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Accreditation Statement

Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 1.0 contact hour, including 0.0 pharmacotherapeutic contact hour, is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relevant Financial Relationships

Integritas Communications and Global Education Group adhere to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas. All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies

Kelly Cooper, MD, MPH, FASAM has nothing to disclose.

The planners and managers at Integritas Communications and Global Education Group have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Mara Simpson prior to the live event at msimpson@integritasgrp.com.

Contact Information

For information about the accreditation (ACCME credit) of this program, please contact Integritas at info@exchangecme.com.

For information about the accreditation (ANCC) of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.